Terns Pharmaceuticals, Inc.

TickerCurrent Price% Daily ChangeVolume (1,000s)Average Volumn (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024
TERN$5.25-6.838%1,0361,618$446$6.49-19.2%

Contact Information

Terns Pharmaceuticals, Inc.
1065 East Hillsdale Boulevard
Suite 100
Foster City, CA 94404
United States

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs.